Bruce Greenberg joined as our Vice President, Controller in December 2019. He brings more than 25 years of accounting and financial operations experience to Aldeyra. Most recently, Mr. Greenberg was the Corporate Controller at Karyopharm Therapeutics Inc., which develops and commercializes drugs for use in oncological treatments. Prior to Karyopharm, Mr. Greenberg held roles of increasing responsibility at KVH Industries, Berklee College, Harvard Bioscience and MKS Instruments. He began his career as a member of the audit practice of Ernst & Young, where he focused on life science and technology clients. Mr. Greenberg received his B.A. in Economics from Clark University and M.B.A in Accounting from Northeastern University’s D’Amore-McKim School of Business.
Back to Leadership Team & Board of Directors